» Articles » PMID: 38947542

A Rare Case of Pulmonary Mucormycosis and Broncho-esophageal Fistula in a Patient with Poorly Controlled Diabetes

Overview
Journal Clin Case Rep
Date 2024 Jul 1
PMID 38947542
Authors
Affiliations
Soon will be listed here.
Abstract

Key Clinical Message: In patients with poorly controlled diabetes, early recognition of rare fungal infections like pulmonary mucormycosis, especially when presenting with unusual complications such as broncho-esophageal fistula, is critical. Prompt intervention with antifungal therapy and consideration for surgical debridement significantly impact outcomes. Multidisciplinary management is paramount for such complex cases.

Abstract: Mucormycosis is a rare fungal infection caused by the Mucorales. This infection is mostly observed among those with poorly controlled diabetes or immunodeficiency. The most common presentation of the infection among those with poorly controlled diabetes is rhino-orbit-cerebral involvement. In this case report, we provide the history and outcome of a rare case of pulmonary mucormycosis in a patient with poorly controlled diabetes who was simultaneously diagnosed with broncho-esophageal fistula. Our patient was a 32-year-old male with a history of poorly controlled diabetes. Over the months, he had complained of productive coughs and dyspnea, which had lately been joined by dysphagia. He also claimed to have lost considerable weight (10 kg) during the previous 3 months. Barium swallow showed an abnormal flow of contrast between the bronchus and esophagus, suggesting a broncho-esophageal fistula. Computed tomography of the thorax revealed a broncho-esophageal fistula between the left main bronchus (LMB) and esophagus. He had a bronchoscopy the next day, which revealed necrosis and a broncho-esophageal fistula in the LMB. A bronchial biopsy showed typical hyphae with necrotic tissue, indicating mucormycosis. The patient's antimycotic medication (liposomal amphotericin) was started and a prompt surgery consult was ordered. The patient, however, passed away from massive hemoptysis. We described a rare case of pulmonary mucormycosis with broncho-esophageal fistula in a patient with poorly controlled diabetes. The rarity of this combination highlights the associated diagnostic and treatment hurdles. Early detection, antifungal medication, as soon as possible surgical debridement of involved tissues, and a multidisciplinary approach could improve patient outcomes.

Citing Articles

Pulmonary mucormycosis in an immunocompetent young female: a case report and literature review.

Zhang X, Wu Z, Shao S Front Med (Lausanne). 2025; 11():1491489.

PMID: 39776843 PMC: 11703827. DOI: 10.3389/fmed.2024.1491489.

References
1.
Mahalaxmi I, Jayaramayya K, Venkatesan D, Subramaniam M, Renu K, Vijayakumar P . Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res. 2021; 201:111643. PMC: 8258024. DOI: 10.1016/j.envres.2021.111643. View

2.
Badin D, Baker C, Simmons B, Yan S, Zug K . The elusive nature of mucormycosis in an immunocompetent host and the role of a dermatology consult. Clin Case Rep. 2019; 7(11):2187-2189. PMC: 6878074. DOI: 10.1002/ccr3.2479. View

3.
Walsh T, Gamaletsou M, McGinnis M, Hayden R, Kontoyiannis D . Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012; 54 Suppl 1:S55-60. DOI: 10.1093/cid/cir868. View

4.
Smith C, Bannon M, Ashraf A, Kaushik P, Marak C . Bronchoesophageal fistula: An unusual manifestation of lung cancer. Respir Med Case Rep. 2022; 37:101634. PMC: 8956807. DOI: 10.1016/j.rmcr.2022.101634. View

5.
Maertens J, Demuynck H, Verbeken E, Zachee P, Verhoef G, Vandenberghe P . Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant. 1999; 24(3):307-12. DOI: 10.1038/sj.bmt.1701885. View